Trial Profile
Tofogliflozin Reduces 24-h Ambulatory Blood Pressure in inpatients with Type 2 Diabetes and Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2018
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Hypertension in diabetes
- Focus Therapeutic Use
- 12 Mar 2018 Status changed from recruiting to completed.
- 17 Jun 2016 New trial record